Home
Live Updates
ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023 : comparemela.com
ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023
/PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for...
Related Keywords
Florida ,
United States ,
Orange County Convention Center ,
United Kingdom ,
Orlando ,
American ,
Tom Mccarthy ,
James Westcott ,
Prnewswire Thirtyfivebio ,
M Bio Limited ,
Innovation Centre On Milton Park ,
Third Company ,
American Association For Cancer Research ,
M Bio ,
Third Company Created ,
Jointly Incubated ,
Canaan Partners ,
New Precision Medicine Approach ,
Gastrointestinal Diseases ,
Targeted Inhibition ,
First In Class Small ,
Highlight Preclinical Data Validating ,
Novel Cancer Target ,
Describing Discovery ,
Fivebio Limited ,
American Association ,
Cancer Research ,
Annual Meeting ,
Grey Wolf Therapeutics ,
Pathios Therapeutics ,
Digestive Tract Cancers ,
Orange County Convention ,
Innovation Centre ,
Milton Park ,
Strategic Partners ,
Thirtyfivebio ,
comparemela.com © 2020. All Rights Reserved.